These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 17310044
1. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease. Ann Intern Med; 2007 Apr 17; 146(8):I12. PubMed ID: 17310044 [No Abstract] [Full Text] [Related]
2. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Ann Intern Med; 2007 Apr 17; 146(8):545-55. PubMed ID: 17310045 [Abstract] [Full Text] [Related]
3. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD? Gillissen A. Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105; author reply 106-7. PubMed ID: 18565963 [No Abstract] [Full Text] [Related]
4. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K. Treat Respir Med; 2004 Jul 01; 3(3):173-81. PubMed ID: 15219176 [Abstract] [Full Text] [Related]
5. Do we need three players in COPD treatment? Maestrelli P, Mason P, Costa F, Paggiaro P. Respiration; 2013 Jul 01; 86(4):275-6. PubMed ID: 23988429 [No Abstract] [Full Text] [Related]
6. The INSPIRE trial results: are they truly breathtaking? Chui D, Tejani AM. Am J Respir Crit Care Med; 2009 Jan 01; 179(1):80; author reply 80-1. PubMed ID: 19098157 [No Abstract] [Full Text] [Related]
7. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Hodder R, Kesten S, Menjoge S, Viel K. Int J Chron Obstruct Pulmon Dis; 2007 Jan 01; 2(2):157-67. PubMed ID: 18044688 [Abstract] [Full Text] [Related]
8. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease]. Baloira Villar A, Vilariño Pombo C. Arch Bronconeumol; 2005 Mar 01; 41(3):130-4. PubMed ID: 15766465 [Abstract] [Full Text] [Related]
9. Tiotropium versus salmeterol in COPD. Schembri S. N Engl J Med; 2011 Jun 30; 364(26):2553; author reply 2553-4. PubMed ID: 21714655 [No Abstract] [Full Text] [Related]
10. Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal? Brown SM. Ann Intern Med; 2007 Dec 18; 147(12):882; author reply 882-3. PubMed ID: 18087061 [No Abstract] [Full Text] [Related]
11. Tiotropium versus salmeterol in COPD. Oba Y. N Engl J Med; 2011 Jun 30; 364(26):2553; author reply 2553-4. PubMed ID: 21714654 [No Abstract] [Full Text] [Related]
12. Tiotropium versus salmeterol in COPD. Lloret-Linares C, Bergmann JF. N Engl J Med; 2011 Jun 30; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656 [No Abstract] [Full Text] [Related]
14. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study. Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group. Respir Med; 2012 Mar 30; 106(3):382-9. PubMed ID: 21975275 [Abstract] [Full Text] [Related]
16. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?]. Calverley P. MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294 [No Abstract] [Full Text] [Related]